Reported 3 days ago
SpringWorks Therapeutics (SWTX) experienced a significant increase in its stock value following news of potential acquisition discussions with a major pharmaceutical company. Although no formal agreement has been reached, the announcement prompted the cancellation of company meetings and earnings calls, highlighting the deal's importance. The biopharmaceutical firm has shown positive stock performance over the past year amidst a challenging market for small-cap stocks.
Source: YAHOO